ARTICLES

Take a look at our latest articles, providing insight on the latest topics across the pharmaceutical landscape.

Why brands matter in pharma

Why brands matter in pharma

Where have all the pharma brands gone? Brands are all around us and shape our decisions in ways we are not conscious of. So why has there been a steady decline in their creation in pharma? Having embraced the idea of brand building in the 2000s/2010s, there has been a...

SEPARATING HYPE FROM REALITY IN THE WORLD OF AI

SEPARATING HYPE FROM REALITY IN THE WORLD OF AI

In the world of hype surrounding the term ‘Artificial intelligence’ (AI), it’s natural to ask how you can actually define what AI is (and isn’t). With many tech providers offering genuinely innovative and valuable solutions under the banner of AI, whilst others use...

Antibody-Drug Conjugates: the fuel for future growth

Antibody-Drug Conjugates: the fuel for future growth

We're excited to share our comprehensive whitepaper on Antibody-Drug Conjugates (ADCs), a groundbreaking class of targeted cancer therapies. Dive into the details and discover how ADCs are revolutionising oncology.  Here are some of the key highlights:  Mechanism of...

Caregivers: their impact on treatment choice and the patient journey

Caregivers: their impact on treatment choice and the patient journey

The importance of the role that caregivers play in the healthcare landscape cannot be overstated.  Caregivers are playing an even greater role in the patient journey, and the rise in cancer and other chronic diseases means there are now more caregivers than ever. ...

The state of pharma brand planning

The state of pharma brand planning

Brand planning is a vital but much maligned part of pharmaceutical marketing.    All too often, it’s seen as a chore, a box ticking exercise, or something to get done and move on from. The reality couldn’t be further from this!   In a recent webinar, Branding Science...

Why do we ask doctors to predict the future when humans can’t?

Why do we ask doctors to predict the future when humans can’t?

The pharmaceutical insights industry has used fundamentally the same questions for a long time in our research to support pipeline decisions and planning. Questions like: How likely are you to use this product? What percentage of patients would you use it for? Is it...

Insights, Fast and Slow

The new roles of pharma insights and strategy in the age of AI

Get the report Later